The House passed a $28 million emergency funding bill for the Food and Drug Administration to address the shortage of infant formula in the US and provide tighter oversight of the industry.
The legislation was approved Wednesday night on a 231 to 192 vote.
Democrats argued that increasing funding for inspections would help bolster supplies by expediting sourcing of formula from new domestic and international suppliers, which must be FDA-approved.
The House vote occurred hours after President
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.